Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor (vol 62, pg722, 2016)

被引：0
|
作者：
Jazi, M.
Porfiris, G.
机构：
来源：
CANADIAN FAMILY PHYSICIAN | 2016年 / 62卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：877 / 877
页数：1
相关论文
共 50 条
  • [31] Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?
    Somagutta, Manoj Kumar Reddy
    Uday, Utkarsha
    Shama, Nishat
    Bathula, Narayana Reddy
    Pendyala, Siva
    Mahadevaiah, Ashwini
    Mahmutaj, Greta
    Ngardig, Ngaba Negumadji
    KOREAN JOURNAL OF FAMILY MEDICINE, 2022, 43 (06): : 361 - 366
  • [32] "The Bitter Truth of Sugar"-Euglycemic Diabetic Ketoacidosis due to Sodium-glucose Cotransporter-2 Inhibitors: A Case Series
    Shah, Mehul
    Pathrose, Edwin
    Bhagwat, Nikhil M.
    Chandy, David
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (01) : 123 - 126
  • [33] Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers
    Somagutta, Manoj R.
    Agadi, Kuchalambal
    Hange, Namrata
    Jain, Molly S.
    Batti, Erkan
    Emuze, Bernard O.
    Amos-Arowoshegbe, Elizabeth O.
    Popescu, Sorin
    Hanan, Saad
    Kumar, Varadha Retna
    Pormento, Kezia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
  • [34] Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
    Meyer, Emily J.
    Mignone, Edward
    Hade, Anthony
    Thiruvenkatarajan, Venkatesan
    Bryant, Robert V.
    Jesudason, David
    DIABETES CARE, 2020, 43 (11) : E181 - E184
  • [35] Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
    Kamath, Sangita D.
    Kumar, Umesh
    Shrivastava, Vikki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [36] Postoperative Euglycemic Ketoacidosis in Type 2 Diabetes Associated with Sodium-Glucose Cotransporter 2 Inhibitor: Insights Into Pathogenesis and Management Strategy
    Chandrakumar, Harshith P.
    Chillumuntala, Seeta
    Singh, Gurcharan
    McFarlane, Samy I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [37] Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment
    Storgaard, Heidi
    Bagger, Jonatan I.
    Knop, Filip K.
    Vilsboll, Tina
    Rungby, Jorgen
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 118 (02) : 168 - 170
  • [38] Sodium-glucose Cotransporter 2 Inhibitor-induced Diabetic Ketoacidosis in a Type 2 Diabetic Patient
    Tello, Edna M. Juarez Ramirez
    Orellana-Barrios, Menfil A.
    Nugent, Kenneth
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2016, 351 (06): : 634 - 635
  • [39] Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition
    Peters, Anne L.
    Buschur, Elizabeth O.
    Buse, John B.
    Cohan, Pejman
    Diner, Jamie C.
    Hirsch, Irl B.
    DIABETES CARE, 2015, 38 (09) : 1687 - 1693
  • [40] Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors
    Auerbach, Jonathan S.
    Gershengorn, Hayley B.
    Aljure, Oscar D.
    Lamelas, Joseph
    Patel, Samira S.
    Ferreira, Tanira D.
    Gonzalez, Lazaro A.
    Cabrera, Jorge L.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 956 - 963
12345